Waters Corporation (WAT) |
| 418.64 1.55 (0.37%) 09-16 16:00 |
| Open: | 417.86 |
| High: | 424.73 |
| Low: | 415.935 |
| Volume: | 710,793 |
| Market Cap: | 31,310(M) |
| PE Ratio: | 30.6 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Diagnostics & Research |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 497.82 |
| Resistance 1: | 426.22 |
| Pivot price: | 411.28 |
| Support 1: | 405.66 |
| Support 2: | 392.95 |
| 52w High: | 426.22 |
| 52w Low: | 282.77 |
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
| EPS | 3.930 |
| Book Value | 154.700 |
| PEG Ratio | 1.54 |
| Gross Profit | 26.683 |
| Profit Margin (%) | 3.59 |
| Operating Margin (%) | 9.42 |
| Return on Assets (ttm) | 3.6 |
| Return on Equity (ttm) | 1.9 |
Wed, 16 Sep 2026
Waters stock heads into the open after a 0.88 percent gain - ad-hoc-news.de
Mon, 14 Sep 2026
[PRNewswire] Waters Launches BD FACSDiscover A7 Cell Analyzer - en.yna.co.kr
Mon, 14 Sep 2026
Should Product Launch Require Action From Waters (WAT) Investors? - simplywall.st
Mon, 14 Sep 2026
A lab machine can analyze more than 50 traits in one cell. Waters launched it globally. - Stock Titan
Mon, 14 Sep 2026
Waters Corporation (NYSE:WAT) Launches BD FACSDiscover A7 Globally - TradingView
Mon, 14 Sep 2026
Waters Corporation (WAT) Stock Analysis: Navigating Its 113.40% Revenue Growth Amidst a Promising Analyst Consensus - DirectorsTalk Interviews
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |